F. Hoffmann-La Roche Ltd, Abbott, and Danaher are dominating the Middle East and Africa Lab Diagnostics Market in 2021

Middle East and Africa Lab Diagnostics Market is expected to grow with the CAGR of 5.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-lab-diagnostics-market

Middle East and Africa Lab Diagnostics Market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Middle East and Africa Lab Diagnostics Market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In September 2021, F. Hoffmann-La Roche Ltd has announced the launch of three molecular PCR diagnostic test panels to simultaneously detect and differentiate common respiratory pathogens. This product launch was anticipated to enhance revenue growth of the company

F. Hoffmann-La Roche Ltd is the dominating player in the Middle East and Africa Lab Diagnostics Market. The other key players in the market are Abbott, Danaher, Thermo Fisher Scientific Inc., Siemens Healthineers AG, bioMérieux SA, BD., Merck KGaA, Bio-Rad Laboratories, Inc., Quidel Corporation., QIAGEN, Sysmex Corporation, DiaSorin S.p.A., Tulip Diagnostics (P) Ltd, Ortho Clinical Diagnostics., OPKO Health, Inc., Cardinal Health., Werfen, Trinity Biotech, OPTI Medical Systems, Inc. (Subsidiary of IDEXX LABORATORIES, INC.), Erba Mannheim, and Biosino Bio-Technology and Science Inc. among others.

Middle East and Africa Lab Diagnostics MarketF. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche Ltd was founded in the year 1896, and is headquartered in Basel, Switzerland. Company is exclusively focusing on developing new medicines and diagnostic tests. The company operates its business via two business segments including pharmaceuticals, diagnostics in which diagnostics is the market focused segment. The company has many product categories including centralised and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care in which molecular diagnostics is market focused category.

  • In March 2021, F. Hoffmann-La Roche Ltd has announced the launch of eight new configurations for cobas pro integrated solutions, in countries accepting the CE mark. As a result, this analyser can deliver up to 4,400 tests per hour, doubling its previous testing capacity. This launch was anticipated to up-surge company geographical presence

The company has presence across Asia-Pacific, Europe, Middle East and Africa, North America, and South America. The company also has various subsidiaries including Roche Holding Ltd. (Switzerland), Chugai Pharmaceutical Co., Ltd. (Japan), Roche Algérie SPA (Algeria), and Roche Diabetes Care Australia Pty Limited (Australia) among others.

Abbott

Abbott is headquartered in Chicago, United States and was founded in 1888. The company is focused on diagnostics, medical devices, nutrition and branded generic pharmaceuticals. The company has several business segments including established pharmaceutical products, nutritional products, diagnostic products, medical devices and others in which diagnostic products is focused segment. The company has several product categories including consumers and healthcare professionals in which healthcare professionals is the market focused category.

For instance,

  • In March 2020, Abbott announced that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular test for novel coronavirus (COVID-19). This has helped the company in enhancing sales growth of the company

 The company has wide presence across Asia-Pacific, Europe, Middle East and Africa, and North America. The company also has various subsidiary companies including Abbott Administration Inc. (Delaware), Abbott Bioresearch Center, Inc. (Delaware), Abbott Cardiovascular Systems Inc. (California), Abbott Cardiovascular, Inc. (Delaware), and others.

Danaher

Danaher was founded in the year 1969, and is headquartered in Washington DC, U.S.A. The company focuses on manufacturing and designing of professional, medical, industrial and commercial products, and services in the sectors of test and Middle East and Africa surement, environmental, life sciences, dental, and industrial technologies. The company operates in three business segments including life sciences, diagnostics & environmental & applied solutions in which diagnostics is the focused segment. The company has many product categories which are life sciences, diagnostics & environmental & applied solutions in which diagnostics is the focused category.

  • In August 2021, Danaher acquired Aldevron who will operate as a standalone operating company and brand within Danaher's Life Sciences segment. This acquisition has increased company’s product portfolio

The company has presence across Asia, Middle East and Africa, Europe, and Americas. The company also has various subsidiaries including Hach (U.S.), Beckman Coulter (U.S.), Pall Corporatiion (U.S.), and Integrated DNA Technologies (U.S.) among others.